ZA922464B - Suppression of thromboxane levels by percutaneous administration of aspirin - Google Patents

Suppression of thromboxane levels by percutaneous administration of aspirin

Info

Publication number
ZA922464B
ZA922464B ZA922464A ZA922464A ZA922464B ZA 922464 B ZA922464 B ZA 922464B ZA 922464 A ZA922464 A ZA 922464A ZA 922464 A ZA922464 A ZA 922464A ZA 922464 B ZA922464 B ZA 922464B
Authority
ZA
South Africa
Prior art keywords
suppression
aspirin
percutaneous administration
thromboxane levels
thromboxane
Prior art date
Application number
ZA922464A
Other languages
English (en)
Inventor
Rudolph M Keimowitz
M Keimowitz Rudolph
Desmond J Fitzgerald
J Fitzgerald Desmond
Original Assignee
Gundersen Med Found
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gundersen Med Found, Univ Vanderbilt filed Critical Gundersen Med Found
Publication of ZA922464B publication Critical patent/ZA922464B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA922464A 1991-04-03 1992-04-03 Suppression of thromboxane levels by percutaneous administration of aspirin ZA922464B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68019591A 1991-04-03 1991-04-03

Publications (1)

Publication Number Publication Date
ZA922464B true ZA922464B (en) 1992-12-30

Family

ID=24730117

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA922464A ZA922464B (en) 1991-04-03 1992-04-03 Suppression of thromboxane levels by percutaneous administration of aspirin

Country Status (12)

Country Link
EP (1) EP0578780B1 (fr)
JP (1) JPH06510984A (fr)
KR (1) KR100247441B1 (fr)
AT (1) ATE244011T1 (fr)
AU (1) AU668352B2 (fr)
CA (1) CA2107587C (fr)
DE (1) DE69233116T2 (fr)
DK (1) DK0578780T3 (fr)
FI (1) FI934324A0 (fr)
NO (1) NO306536B1 (fr)
WO (1) WO1992020343A1 (fr)
ZA (1) ZA922464B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP921157A2 (en) 1991-12-20 1994-10-31 Lohmann Therapie Syst Lts Transdermal system of applying acetilsalicilyc acid in antithrombosys therapy
WO1994013302A1 (fr) * 1991-12-20 1994-06-23 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Systeme d'administration transdermique contenant de l'acide acetylsalicylique pour la therapie antithrombotique et la prophylaxie contre le cancer
DE19616539A1 (de) * 1996-04-25 1997-11-06 Luitpold Pharma Gmbh Acetylsalicylsäure enthaltende alkoholische Lösungen zur perkutanen Anwendung, deren Verwendung zur antithrombotischen Therapie sowie Arzneimittel
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
JP2000351729A (ja) * 1999-06-08 2000-12-19 Shionogi & Co Ltd トロンボキサンａ２受容体拮抗剤の経皮吸収製剤
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AU2002250756A1 (en) * 2001-04-19 2002-11-05 Universite De Montreal A method for decreasing superoxide anion production and for the treatment of diseases associated with oxidative stress
WO2011076401A1 (fr) 2009-12-23 2011-06-30 Holger Schankin Compositions pharmaceutiques sensiblement exemptes d'eau, contenant de l'acide acétylsalicylique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2295753A1 (fr) * 1974-12-23 1976-07-23 Despin Jean Composition a base d'acide acetyl-salicylique a usage topique
FR2496459A1 (fr) * 1980-12-19 1982-06-25 Astier Laboratoires Docteur P Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
DE3583698D1 (de) * 1984-04-23 1991-09-12 Kao Corp Perkutaner absorptions-beschleuniger und diesen enthaltendes praeparat.
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin

Also Published As

Publication number Publication date
AU668352B2 (en) 1996-05-02
KR100247441B1 (ko) 2000-04-01
FI934324A0 (fi) 1993-10-01
NO933529D0 (no) 1993-10-01
DE69233116T2 (de) 2004-08-26
DK0578780T3 (da) 2003-08-18
DE69233116D1 (de) 2003-08-07
CA2107587A1 (fr) 1992-10-04
ATE244011T1 (de) 2003-07-15
NO933529L (no) 1993-11-29
JPH06510984A (ja) 1994-12-08
CA2107587C (fr) 2004-11-23
EP0578780A1 (fr) 1994-01-19
WO1992020343A1 (fr) 1992-11-26
AU2014292A (en) 1992-12-30
EP0578780B1 (fr) 2003-07-02
NO306536B1 (no) 1999-11-22

Similar Documents

Publication Publication Date Title
HK1004521A1 (en) Composition in the form of a foam containing 5- aminosalicylic acid for intrarectal administration
HUT65278A (en) Process for producing pyrido-, pyrrolo-, thiazino-, oxazino- and pyrazino-benzazepine derivatives and pharmaceutical preparations containing them
HUT53521A (en) Process for producing pharmaceutical compositions comprising morphine
HUT65192A (en) Process for producing pyrido-, pyrrolo-, thiazino-, oxazino- and pyrazino benzazepine derivatives and pharmaceutical preparations containing
EP0449247A3 (en) Pharmaceutical composition containing galanthamine for treating alcoholism
HUT55795A (en) Process for producing aromatic steroide 5-alpha-reductase inhibitors and pharmaceutical compositions containing them
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
NO168227C (no) Analogifremgangsmaate til fremstilling av et naeringsmiddelfra en naeringsmiddelblanding.
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
IL64091A (en) Arylimidazo(1,2-a)pyridine acetamide derivatives,their preparation and pharmaceutical compositions containing them
MY102038A (en) 4-substituted androstendione derivatives and process for their preparation
ZA885944B (en) Transdermal therapeutic system
GR880100509A (en) Tripeptides used as stimulating of immunity mechanisms used also for prevention
ZA922464B (en) Suppression of thromboxane levels by percutaneous administration of aspirin
IL112036A0 (en) Methods of increasing thrombomodulin expression
IL88971A (en) Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them
IL111580A (en) Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating sleep disorders
IL111579A (en) Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating desynchronization disorders
HUT48119A (en) Process for producing pharmaceutical compositions against addiction to nicotine and comprising 2-pyrimidinyl-1-piperazine derivatives
GB2162748A (en) Medicinal composition for the treatment or prevention of acne by oral administration
HUT50633A (en) Process for producing pharmaceutical compositions comprising 1,4-dihydropyridine derivatives
HUT65256A (en) Process for producing 2-mercapto methylene-tetrahydronaphtalene-2-carboxamide derivatives and pharmaceutical preparations containing them
ES2165382T3 (es) Agentes antiateroescleroticos.
BG94585A (en) Method for the preparation of an analgesic medicament
GB8812620D0 (en) Pharmaceutical composition for treatment of migraine &c